Lupus & antiphospholipid syndrome
Induction treatment for lupus nephritis at a high-complexity hospital in Chile
Authors' conclusion
This study did not find significant differences in the clinical response to IVC or MMF at 6 months.
Study context
- Population
- Lupus nephritis (LN) patients at a high-complexity hospital in Chile, 2016–2021 (median age 29 years; 90% women)
- Participants
- 72 patients
- Exposure
- Intravenous cyclophosphamide (IVC) vs mycophenolate mofetil (MMF) as induction therapy for LN
- Outcome
- Response to treatment
- Follow-up
- 6 months
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
- Response to treatment did not differ significantly between IVC and MMF
Observational data: associations, not effects.
Original publication
Induction treatment for lupus nephritis at a high-complexity hospital in Chile. Lupus. Published 23 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →